CheckMan Stock Market Overview

Two AI giants just posted blockbuster quarters, yet only one is watching its stock slide while its CEO faces a board investigation. What separates their paths, and could the rankings flip after NVIDIA's next earnings report?

Analysts see more upside as the beauty company strengthens its China business and pursues higher sales and margins.

Compugen Ltd. maintains a "Buy" rating, driven by advancing clinical programs and strong partnership with AstraZeneca for rilvegostomig. The company's lead asset, COM701, is on track for phase 1/2 MAIA-ovarian trial results in Q1 2027, targeting a major unmet need in relapsed PSOC. The AstraZeneca partnership, leveraging CGEN's COM902 TIGIT component in rilvegostomig, underpins 12 ongoing phase 3 trials across multiple solid tumors with key data in 2027.

SAN FRANCISCO, Nov. 10, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation firm, alerts investors in CVRx, Inc. (NASDAQ: CVRX) to a class action lawsuit filed in federal court. The filing follows disclosures of a U.S. Department of Justice Civil Investigative Demand ("CID"), severe cuts to revenue guidance, commercial sales force disruption, and the sudden termination of the company's Chief Revenue Officer.

Alphabet Class C shares fell $16.39 in a single session after a report that Gemini 3.5 Pro was months behind schedule. Exchange Act claims allege that the June 2026 launch commitment carried no meaningful cautionary language while disappointing training results went undisclosed Alphabet Class C shares fell $16.39 in a single session after a report that Gemini 3.5 Pro was months behind schedule. Exchange Act claims allege that the June 2026 launch commitment carried no meaningful cautionary language while disappointing training results went undisclosed

Billions in capex push Equinix's free cash flow below zero, and its earnings multiple looks stretched. Yet one overlooked metric tells a very different story about the dividend, and a rising debt pile could still threaten it.

SAN FRANCISCO, Nov. 10, 2026 /PRNewswire/ -- Hagens Berman, a prominent national trial law firm specializing in securities fraud and shareholder rights, alerts investors in NVIDIA Corporation (NASDAQ: NVDA) to a class action lawsuit filed in federal court. The firm encourages NVIDIA investors who purchased shares and suffered substantial losses to submit your losses now.

Advanced Micro Devices AMD shares continued their rally on Tuesday, with fresh details of the chipmaker's financial ties with Anthropic further boosting sentiment. AMD shares rose around 5% in morning trading, following a surge of more than 13% on Monday.

Key Dates and Disclosure Events Shareholders Need to Know. The complaint traces how Chemours allegedly reaffirmed its 2026 outlook from February through May while an oversupplied Opteon aftermarket channel was allegedly eroding the demand behind it Key Dates and Disclosure Events Shareholders Need to Know. The complaint traces how Chemours allegedly reaffirmed its 2026 outlook from February through May while an oversupplied Opteon aftermarket channel was allegedly eroding the demand behind it

Nov 10 (Reuters) - Alphabet's Google (GOOGL.